Literature DB >> 31539456

Surgical site infection and risk factors following right lobe living donor liver transplantation in adults: A single-center prospective cohort study.

Aydin Aktas1, Cuneyt Kayaalp1, Orgun Gunes1, Cihan Gokler1, Ufuk Uylas1, Egemen Cicek1, Yasemin Ersoy2, Adem Kose2, Yasar Bayindir2, Cemalettin Aydin3, Sezai Yilmaz3.   

Abstract

INTRODUCTION: Surgical site infection (SSI) is an important cause of decreased graft survival, prolonged hospital stay, and higher costs following living donor liver transplantation. There are several risk factors for SSI. In this cohort study, we aimed to investigate the incidence of SSI at our center and the associated risk factors.
MATERIALS AND METHODS: Adult right lobe living donor liver transplantations were included in this prospective cohort. Patients who died postoperatively within 3 days; patients with infected ascites or open abdomen, cadaveric, or pediatric transplants; and patients with biologic or cryopreserved vascular grafts were excluded. Patients' demographic characteristics and perioperative surgical findings were recorded. SSI follow-up was continued for 90 days. CDC-2017 criteria were used to diagnose SSI. In the presence of superficial, deep, and organ/space SSI, only the organ in the poorest condition was included in SSI evaluation. The patients were administered similar to antibiotic prophylaxes and immunosuppressive protocols.
RESULTS: A total of 101 patients were enrolled in this study, of which 30 (29.7%) were diagnosed with SSI. Organ/space, only deep, and only superficial SSI were noted in 90% (27/30), 6.7% (2/30), and 3.3% (1/30) of the patients, respectively. Twenty-five of 30 patients with SSI had a remote site infection. One or more bacteria observed in cultures were obtained from 28 patients. A donor-recipient age difference of >10 years, cold ischemia lasting for ≥150 minutes, surgical duration of ≥600 minutes, intraoperative hemorrhage of ≥1000 mL, intraoperative blood transfusion, biliary leak or stricture, prolonged mechanical ventilation, prolonged intensive care unit and hospital stay, remote site infection, and the need for reoperation were associated with increased SSI incidence. Preoperative and intraoperative levels of blood glucose, albumin, and hemoglobin were not associated with SSI. A donor-recipient age difference of >10 years, remote site infection, and biliary leak were found to be independent risk factors for SSI. Hospital mortality with and without SSIs was 6.7% vs 4.4%, P = .61. DISCUSSION: Organ/space SSIs were the essential part of SSIs following right lobe living donor liver transplantations. Donor-recipient age gap, prolonged cold ischemia time, complicated surgery, and postoperative biliary complications were the main causes of SSIs. Although they did not increase the perioperative mortality, they promote increased rate of reoperations, remote infections, prolonged intensive care unit, and hospital stays.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatic; infection; prophylaxis; transplantation; wound

Mesh:

Year:  2019        PMID: 31539456     DOI: 10.1111/tid.13176

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Surgical Revision Promotes Presence of Enterococcus spp. in Abdominal Superficial Surgical Site Infections.

Authors:  Matthias Mehdorn; Woubet Tefera Kassahun; Norman Lippmann; Uwe Scheuermann; Linda Groos; Dorina Buchloh; Boris Jansen-Winkeln; Ines Gockel
Journal:  J Gastrointest Surg       Date:  2021-10-18       Impact factor: 3.452

2.  Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.

Authors:  Melinda H MacDonald; Gary Zhang; Laura Tasse; Daidong Wang; Hector De Leon; Richard Kocharian
Journal:  J Mater Sci Mater Med       Date:  2021-09-30       Impact factor: 3.896

3.  Risk Stratification for Organ/Space Surgical Site Infection in Advanced Digestive System Cancer.

Authors:  Chen Sun; Hui Gao; Yuelun Zhang; Lijian Pei; Yuguang Huang
Journal:  Front Oncol       Date:  2021-11-09       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.